Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

Patients with vs without nonarteritic anterior ischemic optic neuropathy demonstrated an elevated risk for stroke. Individuals with vs without nonarteritic anterior ischemic optic neuropathy ...

With the exception of giant cell arteritis and hypertensive retinopathy, fundal signs related to systemic vasculitides are uncommon, or even rare. The vasculitic process typically affects the ...

Objective Evaluating the potential role of neuromuscular ultrasonography (NMUS) in assessing optic nerve affection in patients with systemic lupus erythematosus (SLE), compared with healthy controls ...

Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy, even when ...

An increased risk for NAION was seen among participants with T2D, overweight/obesity receiving semaglutide vs non-GLP1-RA meds. Jimena Tatiana Hathaway, M.D., M.P.H., from the Harvard T.H. Chan ...